1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cholelithiasis Global Clinical Trials Review, H1, 2015

Cholelithiasis Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 61 pages

Cholelithiasis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, H1, 2015" provides data on the Cholelithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholelithiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cholelithiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cholelithiasis Global Clinical Trials Review, H1, 2015
Introduction 6
Cholelithiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cholelithiasis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cholelithiasis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cholelithiasis 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Cholelithiasis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
USGI Medical, Inc. 31
Clinical Trial Overview of USGI Medical, Inc. 31
Catalysis, S.L. 32
Clinical Trial Overview of Catalysis, S.L. 32
Alternova A/S 33
Clinical Trial Overview of Alternova A/S 33
Clinical Trial Overview of Top Institutes / Government 34
University of California, San Diego 34
Clinical Trial Overview of University of California, San Diego 34
Islamic Azad University of Tabriz 35
Clinical Trial Overview of Islamic Azad University of Tabriz 35
Mansoura University 36
Clinical Trial Overview of Mansoura University 36
G. Hatzikosta General Hospital 37
Clinical Trial Overview of G. Hatzikosta General Hospital 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
Universidad Juarez Durango 40
Clinical Trial Overview of Universidad Juarez Durango 40
Hospital Son Llatzer 41
Clinical Trial Overview of Hospital Son Llatzer 41
Kuopio University Hospital 42
Clinical Trial Overview of Kuopio University Hospital 42
University of Missouri 43
Clinical Trial Overview of University of Missouri 43
Five Key Clinical Profiles 44
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 61

List of Tables

Cholelithiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cholelithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cholelithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cholelithiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cholelithiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cholelithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Cholelithiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cholelithiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cholelithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cholelithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cholelithiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Cholelithiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Cholelithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Cholelithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Cholelithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Cholelithiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Cholelithiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by USGI Medical, Inc., 2015* 31
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalysis, S.L., 2015* 32
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alternova A/S, 2015* 33
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015* 34
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2015* 35
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mansoura University, 2015* 36
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by G. Hatzikosta General Hospital, 2015* 37
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 39
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidad Juarez Durango, 2015* 40
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Son Llatzer, 2015* 41
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2015* 42
Cholelithiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2015* 43

List of Figures

Cholelithiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cholelithiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cholelithiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cholelithiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cholelithiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cholelithiasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cholelithiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cholelithiasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cholelithiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cholelithiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Cholelithiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Cholelithiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cholelithiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cholelithiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Cholelithiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Cholelithiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Cholelithiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Cholelithiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 59

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.